Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Central Nervous System Distribution of the Ataxia-Telangiectasia Mutated Kinase Inhibitor AZD1390: Implications for the Treatment of Brain Tumors

Journal of Pharmacology and Experimental Therapeutics(2022)10.1124/jpet.122.001230Source: DataRank Database

Central Nervous System Distribution of the Ataxia-Telangiectasia Mutated Kinase Inhibitor AZD1390: Implications for the Treatment of Brain Tumors is a research paper published in Journal of Pharmacology and Experimental Therapeutics (2022). On theSindex it has a DataRank of 0. It has been cited 11 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access11 citations

Download PDF

Cite:

Linked data & code

nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 1.50)OA: bronzeTopics (33)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Wenjuan Zhang ORCID,Jiajia Chen ORCID,Shiv K. Gupta ORCID,Danielle M. Burgenske ORCID,Jann N. Sarkaria ORCID

Live enrichment

PubMed:36137710 PMC:PMC9513858 OpenAlex:https://openalex.org/W4289918864

NINDS NIH HHS

Grant: R24 NS092940

NCI NIH HHS

Grant: U19 CA264362

NCI NIH HHS

Grant: U54 CA210180

NCI NIH HHS

Grant: U01 CA227954

NCI NIH HHS

Grant: P50 CA108961

FWCI

1.50

Citation Percentile

0.8%

Citation Trend

2023

2024

2025

bronzeLicense: https://www.elsevier.com/legal/tdmrep-license

journalhttps://jpet.aspetjournals.org/content/jpet/383/1/91.full.pdf

BRONZEhttps://jpet.aspetjournals.org/content/jpet/383/1/91.full.pdf

publisherhttps://jpet.aspetjournals.org/content/jpet/383/1/91.full.pdf

publisherhttps://api.elsevier.com/content/article/PII:S0022356524003379?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0022356524003379?httpAccept=text/plain

Fields of Study

Glioma Diagnosis and TreatmentDrug Transport and Resistance MechanismsDNA Repair MechanismsMedicine

MeSH Terms

ATP Binding Cassette Transporter, Subfamily G, Member 2AnimalsAntineoplastic AgentsAtaxia TelangiectasiaBlood-Brain BarrierBrainBrain NeoplasmsGlioblastomaHumansNeoplasm ProteinsATP Binding Cassette Transporter, Subfamily BATP Binding Cassette Transporter, Subfamily B, Member 1Protein Kinase InhibitorsMice

Keywords

Brain tumorCentral nervous systemCancer researchIn vivoGliomaPharmacologyMedicineEffluxP-glycoproteinBiologyPathologyDrug resistanceInternal medicineMultiple drug resistanceBiochemistry

Sustainable Development Goals

SDG 0: Good health and well-being

Central Nervous System Distribution of the Ataxia-Telangiectasia Mutated Kinase Inhibitor AZD1390: Implications for the Treatment of Brain Tumors

FAIR Checklist

Authors (7)

Funding (5 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)